Partnership with Hamburg Trading Corp to advance applied testing and life science research Serving as a learning hub to empower the next generation of Filipino scientists through hands-on access to molecular workflows Facility designed to remove logistical barriers for researchers, enabling on-site evaluation without the need for internal equipment clearances Singapore, Singapore – QIAGEN, a […]
Board Chair Maria Rankka has today notified the Board of Directors that she will step down as Board Chair and board member of BICO Group AB (publ) effective 31 July 2026. Board members Susanne Lithander and Johan Westman have also informed the Board that they will leave their Board assignments at the same time. The […]
Cambridge, UK – bit.bio, the Cambridge-based human cell programming company, has today announced the launch of two new cell culture media kits designed to make human cell-based research significantly more accessible and affordable for laboratories worldwide. Developed for use with bit.bio’s human iPSC-derived ioGlutamatergic Neurons and ioMicroglia, the easy-to-use media kits remove one of the major […]
AnalytiChem consolidates chemicals product expertise, innovation and heritage under one unified global brand AnalytiChem brings together Bernd Kraft, Chem-Lab and SCP Science under a unified global AnalytiChem product brand Eschborn, Germany — AnalytiChem, manufacturer of specialized chemicals, reagents, accredited standard, equipment and consumables, has announced that the brand transition of its chemical product ranges, currently […]
Simplifying label-free imaging analysis for more confident real-time cell analysis SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software […]
Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion). Darmstadt, Germany Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) Proposed acquisition expected to be immediately accretive to sales growth and EBITDA pre margin post-closing, and EPS […]
Industry veteran will strengthen BioIVT’s scientific strategy by advancing the quality, characterization, and applicability of biospecimens to meet emerging research needs WOODBURY, NY – BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it has appointed Sean Downing, PhD, to its Scientific Advisory Board to continue advancing the […]
IMU’s AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time. Waters Biosciences’ technologies, including BD FACSDiscover™ and BD Rhapsody™ Instruments, will be used with IMU’s AI analytics in research to deliver deeper, population-level disease insights. Partnership supports IMU’s expansion of […]
Männedorf, Switzerland — Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging NVIDIA BioNeMo Agent Toolkit. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to […]
ANKENY, Iowa — Proliant Health & Biologicals, a global leader in purified proteins, today announced the commercial launch of AlbufreeDX, a recombinant human albumin (rHA) designed to meet the growing demand for high-performance, animal-free ingredients across diagnostic and life science applications. For more than two decades, Proliant has been a trusted manufacturer of albumin and other […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
